GLP-1 RECEPTOR AGONISTS HAVING IMPROVED PHARMACOLOGICAL AND DRUG DELIVERY PROPERTIES

Disclosed are polypeptides, compositions, and methods useful for activating a glucagon-like peptide- 1 (GLP-1) receptor and treating or preventing diseases or disorders at least partially mediated by glucagon-like peptide 1 (GLP-1). L'invention concerne des polypeptides, des compositions et des...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GRIBKOFF, Valentin, DILLER, David, SWANSON, Jon, SHRIER, Allison, PENTELUTE, Bradley, SAWYER, Jonathon, GUNASEKERA, Dinara, SAWYER, Tomi, AUDIE, Joseph, SANTIAGO, Solimar
Format: Patent
Sprache:eng ; fre
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator GRIBKOFF, Valentin
DILLER, David
SWANSON, Jon
SHRIER, Allison
PENTELUTE, Bradley
SAWYER, Jonathon
GUNASEKERA, Dinara
SAWYER, Tomi
AUDIE, Joseph
SANTIAGO, Solimar
description Disclosed are polypeptides, compositions, and methods useful for activating a glucagon-like peptide- 1 (GLP-1) receptor and treating or preventing diseases or disorders at least partially mediated by glucagon-like peptide 1 (GLP-1). L'invention concerne des polypeptides, des compositions et des méthodes utiles pour activer un récepteur de peptide-1 de type glucagon (GLP-1) et traiter ou prévenir des maladies ou des troubles au moins partiellement médiés par le peptide 1 de type glucagon (GLP-1).
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2022266068A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2022266068A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2022266068A23</originalsourceid><addsrcrecordid>eNqNyrEKwjAQANAuDqL-w4FzoUYorkdyJoE0Cdc04lSKxEm0UP8fHfwAp7e8dZW0i_UBmCTFFBhQB2_71IPBbL0G20UOmRREg9yhDC5oK9EBegWKBw2KnM3EV_jGSJws9dtqdZ8eS9n93FT7MyVp6jK_xrLM0608y3u8BNEIIdq2aU8ojv-tD_lGMT0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>GLP-1 RECEPTOR AGONISTS HAVING IMPROVED PHARMACOLOGICAL AND DRUG DELIVERY PROPERTIES</title><source>esp@cenet</source><creator>GRIBKOFF, Valentin ; DILLER, David ; SWANSON, Jon ; SHRIER, Allison ; PENTELUTE, Bradley ; SAWYER, Jonathon ; GUNASEKERA, Dinara ; SAWYER, Tomi ; AUDIE, Joseph ; SANTIAGO, Solimar</creator><creatorcontrib>GRIBKOFF, Valentin ; DILLER, David ; SWANSON, Jon ; SHRIER, Allison ; PENTELUTE, Bradley ; SAWYER, Jonathon ; GUNASEKERA, Dinara ; SAWYER, Tomi ; AUDIE, Joseph ; SANTIAGO, Solimar</creatorcontrib><description>Disclosed are polypeptides, compositions, and methods useful for activating a glucagon-like peptide- 1 (GLP-1) receptor and treating or preventing diseases or disorders at least partially mediated by glucagon-like peptide 1 (GLP-1). L'invention concerne des polypeptides, des compositions et des méthodes utiles pour activer un récepteur de peptide-1 de type glucagon (GLP-1) et traiter ou prévenir des maladies ou des troubles au moins partiellement médiés par le peptide 1 de type glucagon (GLP-1).</description><language>eng ; fre</language><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20221222&amp;DB=EPODOC&amp;CC=WO&amp;NR=2022266068A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20221222&amp;DB=EPODOC&amp;CC=WO&amp;NR=2022266068A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GRIBKOFF, Valentin</creatorcontrib><creatorcontrib>DILLER, David</creatorcontrib><creatorcontrib>SWANSON, Jon</creatorcontrib><creatorcontrib>SHRIER, Allison</creatorcontrib><creatorcontrib>PENTELUTE, Bradley</creatorcontrib><creatorcontrib>SAWYER, Jonathon</creatorcontrib><creatorcontrib>GUNASEKERA, Dinara</creatorcontrib><creatorcontrib>SAWYER, Tomi</creatorcontrib><creatorcontrib>AUDIE, Joseph</creatorcontrib><creatorcontrib>SANTIAGO, Solimar</creatorcontrib><title>GLP-1 RECEPTOR AGONISTS HAVING IMPROVED PHARMACOLOGICAL AND DRUG DELIVERY PROPERTIES</title><description>Disclosed are polypeptides, compositions, and methods useful for activating a glucagon-like peptide- 1 (GLP-1) receptor and treating or preventing diseases or disorders at least partially mediated by glucagon-like peptide 1 (GLP-1). L'invention concerne des polypeptides, des compositions et des méthodes utiles pour activer un récepteur de peptide-1 de type glucagon (GLP-1) et traiter ou prévenir des maladies ou des troubles au moins partiellement médiés par le peptide 1 de type glucagon (GLP-1).</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEKwjAQANAuDqL-w4FzoUYorkdyJoE0Cdc04lSKxEm0UP8fHfwAp7e8dZW0i_UBmCTFFBhQB2_71IPBbL0G20UOmRREg9yhDC5oK9EBegWKBw2KnM3EV_jGSJws9dtqdZ8eS9n93FT7MyVp6jK_xrLM0608y3u8BNEIIdq2aU8ojv-tD_lGMT0</recordid><startdate>20221222</startdate><enddate>20221222</enddate><creator>GRIBKOFF, Valentin</creator><creator>DILLER, David</creator><creator>SWANSON, Jon</creator><creator>SHRIER, Allison</creator><creator>PENTELUTE, Bradley</creator><creator>SAWYER, Jonathon</creator><creator>GUNASEKERA, Dinara</creator><creator>SAWYER, Tomi</creator><creator>AUDIE, Joseph</creator><creator>SANTIAGO, Solimar</creator><scope>EVB</scope></search><sort><creationdate>20221222</creationdate><title>GLP-1 RECEPTOR AGONISTS HAVING IMPROVED PHARMACOLOGICAL AND DRUG DELIVERY PROPERTIES</title><author>GRIBKOFF, Valentin ; DILLER, David ; SWANSON, Jon ; SHRIER, Allison ; PENTELUTE, Bradley ; SAWYER, Jonathon ; GUNASEKERA, Dinara ; SAWYER, Tomi ; AUDIE, Joseph ; SANTIAGO, Solimar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2022266068A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><toplevel>online_resources</toplevel><creatorcontrib>GRIBKOFF, Valentin</creatorcontrib><creatorcontrib>DILLER, David</creatorcontrib><creatorcontrib>SWANSON, Jon</creatorcontrib><creatorcontrib>SHRIER, Allison</creatorcontrib><creatorcontrib>PENTELUTE, Bradley</creatorcontrib><creatorcontrib>SAWYER, Jonathon</creatorcontrib><creatorcontrib>GUNASEKERA, Dinara</creatorcontrib><creatorcontrib>SAWYER, Tomi</creatorcontrib><creatorcontrib>AUDIE, Joseph</creatorcontrib><creatorcontrib>SANTIAGO, Solimar</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GRIBKOFF, Valentin</au><au>DILLER, David</au><au>SWANSON, Jon</au><au>SHRIER, Allison</au><au>PENTELUTE, Bradley</au><au>SAWYER, Jonathon</au><au>GUNASEKERA, Dinara</au><au>SAWYER, Tomi</au><au>AUDIE, Joseph</au><au>SANTIAGO, Solimar</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>GLP-1 RECEPTOR AGONISTS HAVING IMPROVED PHARMACOLOGICAL AND DRUG DELIVERY PROPERTIES</title><date>2022-12-22</date><risdate>2022</risdate><abstract>Disclosed are polypeptides, compositions, and methods useful for activating a glucagon-like peptide- 1 (GLP-1) receptor and treating or preventing diseases or disorders at least partially mediated by glucagon-like peptide 1 (GLP-1). L'invention concerne des polypeptides, des compositions et des méthodes utiles pour activer un récepteur de peptide-1 de type glucagon (GLP-1) et traiter ou prévenir des maladies ou des troubles au moins partiellement médiés par le peptide 1 de type glucagon (GLP-1).</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2022266068A2
source esp@cenet
title GLP-1 RECEPTOR AGONISTS HAVING IMPROVED PHARMACOLOGICAL AND DRUG DELIVERY PROPERTIES
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T21%3A51%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GRIBKOFF,%20Valentin&rft.date=2022-12-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2022266068A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true